Skip to content
Disclosery

Eagle Health Investments LP

Follow

13F filer, CIK 1842545, Greenwich, CT

Eagle Health Investments LP reported $603,308,468 across 27 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-08-10. Its ten largest share positions make up 66.11% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001172661-26-003205

Period
2026-06-30
Reported value
$603M
Holdings
27
Top 10 weight
66.11%
New
6
Sold out
7

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ASNDnew+106,158$28.3M
INSMadded+159,859$17M
AXSMnew+65,051$15.9M
IONSnew+194,577$15.4M
DNTHnew+131,344$12.8M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
NTRAreduced-106,030-$28.8M
TERNexited-412,497-$21.7M
BBIOexited-267,031-$19.8M
ASNDexited-86,650-$19.8M
PRCTexited-483,815-$12.1M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001172661-26-003205, largest first. % of portfolio is the value over $603,308,468, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ARGXARGENX SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 74,990 shares; 2024Q4: 74,990 shares; 2025Q1: 74,990 shares; 2025Q2: 77,430 shares; 2025Q3: 77,430 shares; 2025Q4: 62,730 shares; 2026Q1: 76,336 shares; 2026Q2: 76,417 shares 76,417$70.9M11.75%+81Timeline
ICLRICON PUB LTD COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 130,790 shares; 2024Q4: 209,190 shares; 2025Q1: 209,190 shares; 2025Q2: 202,790 shares; 2025Q3: 182,590 shares; 2025Q4: 247,090 shares; 2026Q1: 358,500 shares; 2026Q2: 308,143 shares 308,143$53.5M8.87%-50,357Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 212,000 shares; 2025Q3: 284,100 shares; 2025Q4: 284,100 shares; 2026Q1: 310,281 shares; 2026Q2: 300,685 shares 300,685$45.1M7.48%-9,596Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 513,700 shares; 2024Q4: 513,700 shares; 2025Q1: 443,300 shares; 2025Q2: 428,600 shares; 2025Q3: 271,600 shares; 2025Q4: 210,900 shares; 2026Q1: 224,271 shares; 2026Q2: 384,130 shares 384,130$41M6.79%+159,859Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 419,212 shares; 2024Q4: 419,212 shares; 2025Q1: 382,612 shares; 2025Q2: 366,812 shares; 2025Q3: 366,812 shares; 2025Q4: 366,812 shares; 2026Q1: 505,809 shares; 2026Q2: 624,676 shares 624,676$35.7M5.92%+118,867Timeline
ILMNILLUMINA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 387,354 shares; 2024Q4: 343,361 shares; 2025Q1: 343,361 shares; 2025Q2: 343,361 shares; 2025Q3: 322,261 shares; 2025Q4: 231,161 shares; 2026Q1: 187,413 shares; 2026Q2: 187,413 shares 187,413$33M5.46%0Timeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 269,400 shares; 2025Q3: 363,300 shares; 2025Q4: 363,300 shares; 2026Q1: 494,019 shares; 2026Q2: 555,272 shares 555,272$30.5M5.06%+61,253Timeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 57,300 shares; 2026Q1: 179,322 shares; 2026Q2: 248,322 shares 248,322$30.4M5.05%+69,000Timeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 561,700 shares; 2024Q4: 627,600 shares; 2025Q1: 627,600 shares; 2025Q2: 627,600 shares; 2025Q3: 697,000 shares; 2025Q4: not reported; 2026Q1: 884,121 shares; 2026Q2: 884,121 shares 884,121$29.5M4.89%0Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 935,450 shares; 2025Q4: 1,519,388 shares; 2026Q1: 2,060,427 shares; 2026Q2: 2,060,427 shares 2,060,427$29.2M4.83%0Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 106,158 shares 106,158$28.3M4.69%newTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 115,900 shares; 2026Q1: 119,464 shares; 2026Q2: 120,346 shares 120,346$22.5M3.74%+882Timeline
FTREFORTREA HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 988,772 shares; 2025Q4: 1,218,560 shares; 2026Q1: 1,307,560 shares; 2026Q2: 1,181,274 shares 1,181,274$20.6M3.41%-126,286Timeline
KYMRKYMERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 136,300 shares; 2026Q1: 145,816 shares; 2026Q2: 166,148 shares 166,148$19.1M3.16%+20,332Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 65,051 shares 65,051$15.9M2.64%newTimeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 293,152 shares; 2026Q2: 369,164 shares 369,164$15.8M2.61%+76,012Timeline
ALKSALKERMES PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 81,800 shares; 2025Q4: 81,800 shares; 2026Q1: 238,673 shares; 2026Q2: 297,302 shares 297,302$15.6M2.58%+58,629Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 194,577 shares 194,577$15.4M2.56%newTimeline
TEMTEMPUS AI INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 256,269 shares; 2026Q2: 256,269 shares 256,269$14.8M2.46%0Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 131,344 shares 131,344$12.8M2.12%newTimeline
ATAIATAIBECKLEY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,709,359 shares; 2026Q2: 1,709,359 shares 1,709,359$9.01M1.49%0Timeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 235,093 shares 235,093$4.34M0.72%newTimeline
NTRANATERA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 431,314 shares; 2024Q4: 339,764 shares; 2025Q1: 279,764 shares; 2025Q2: 235,964 shares; 2025Q3: 203,664 shares; 2025Q4: 183,264 shares; 2026Q1: 121,877 shares; 2026Q2: 15,847 shares 15,847$4.3M0.71%-106,030Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,994 shares 1,994$2.39M0.4%newTimeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 7,390 shares; 2024Q4: 4,390 shares; 2025Q1: 4,390 shares; 2025Q2: 4,390 shares; 2025Q3: 4,390 shares; 2025Q4: 4,390 shares; 2026Q1: 4,390 shares; 2026Q2: 4,390 shares 4,390$1.75M0.29%0Timeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 46,300 shares; 2024Q4: 46,300 shares; 2025Q1: 46,300 shares; 2025Q2: 46,300 shares; 2025Q3: 46,300 shares; 2025Q4: 46,300 shares; 2026Q1: 46,300 shares; 2026Q2: 46,300 shares 46,300$1.47M0.24%0Timeline
FRNMPERCEPTIVE CAP SOLUTIONS CORQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 37,686 shares; 2026Q2: 37,686 shares 37,686$410K0.07%0Timeline

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
XBISPDR SERIES TRUST730,000$93.2Mput
TERNTERNS PHARMACEUTICALS INC412,497$21.7Mshares
BBIOBRIDGEBIO PHARMA INC267,031$19.8Mshares
ASNDASCENDIS PHARMA A/S86,650$19.8Mshares
PRCTPROCEPT BIOROBOTICS CORP483,815$12.1Mshares
CNTACENTESSA PHARMACEUTICALS PLC214,291$8.51Mshares
PRCTPROCEPT BIOROBOTICS CORP90,000$2.25Mcall

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001172661-26-003205 base2026-08-10acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001172661-26-003205 Quarter ended 2026-06-302026-08-10acceptance time not in the bulk data set
13F-HR 0001172661-26-002258 Quarter ended 2026-03-312026-05-15acceptance time not in the bulk data set
13F-HR 0001172661-26-000509 Quarter ended 2025-12-312026-02-06acceptance time not in the bulk data set
13F-HR 0001172661-25-004632 Quarter ended 2025-09-302025-11-07acceptance time not in the bulk data set
13F-HR 0001172661-25-003039 Quarter ended 2025-06-302025-08-12acceptance time not in the bulk data set
13F-HR 0001172661-25-001685 Quarter ended 2025-03-312025-05-12acceptance time not in the bulk data set
13F-HR 0001172661-25-000676 Quarter ended 2024-12-312025-02-12acceptance time not in the bulk data set
13F-HR 0001172661-24-004568 Quarter ended 2024-09-302024-11-12acceptance time not in the bulk data set
13F-HR 0001172661-24-003270 Quarter ended 2024-06-302024-08-13acceptance time not in the bulk data set
13F-HR 0001172661-24-002255 Quarter ended 2024-03-312024-05-14acceptance time not in the bulk data set
13F-HR 0001172661-24-000664 Quarter ended 2023-12-312024-02-12acceptance time not in the bulk data set
13F-HR 0001172661-23-003510 Quarter ended 2023-09-302023-10-27acceptance time not in the bulk data set
13F-HR 0001172661-23-003066 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0001172661-23-002041 Quarter ended 2023-03-312023-05-12acceptance time not in the bulk data set
13F-HR 0001172661-23-000774 Quarter ended 2022-12-312023-02-13acceptance time not in the bulk data set
13F-HR 0001172661-22-002438 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0001842545-22-000007 Quarter ended 2022-06-302022-08-11acceptance time not in the bulk data set
13F-HR 0001842545-22-000005 Quarter ended 2022-03-312022-05-12acceptance time not in the bulk data set
13F-HR 0001842545-22-000003 Quarter ended 2021-12-312022-02-10acceptance time not in the bulk data set
13F-HR 0001842545-21-000005 Quarter ended 2021-09-302021-10-20acceptance time not in the bulk data set
13F-HR 0001842545-21-000004 Quarter ended 2021-06-302021-07-19acceptance time not in the bulk data set
13F-HR 0001842545-21-000003 Quarter ended 2021-03-312021-04-23acceptance time not in the bulk data set
13F-HR 0001842545-21-000002 Quarter ended 2020-12-312021-02-04acceptance time not in the bulk data set